Harrow IncNASDAQ:HROW
- LAST PRICE17.9500
- TODAY'S CHANGE (%)0.1100 (0.6166%)
- Bid / Lots16.5500/ 1
- Ask / Lots18.2000/ 1
- Open / Previous Close18.0900 / 17.8400
- Day Range
- 52 Week Range
- Volume947,144
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | HROW |
|---|---|---|
| 09:32 ET | 3242 | 17.9 |
| 09:34 ET | 100 | 17.9 |
| 09:36 ET | 1639 | 18 |
| 09:38 ET | 308 | 18 |
| 09:39 ET | 391 | 17.99 |
| 09:41 ET | 500 | 17.99 |
| 09:43 ET | 2136 | 18 |
| 09:45 ET | 4613 | 18.06 |
| 09:48 ET | 13637 | 18.02 |
| 09:50 ET | 2113 | 18.03 |
| 09:52 ET | 800 | 18.03 |
| 09:54 ET | 1472 | 18.21 |
| 09:56 ET | 1656 | 18.15 |
| 09:59 ET | 831 | 18.1 |
| 10:03 ET | 157 | 18.095 |
| 10:06 ET | 318 | 18.05 |
| 10:08 ET | 500 | 18.05 |
| 10:10 ET | 200 | 18.07 |
| 10:12 ET | 1174 | 18.05 |
| 10:14 ET | 200 | 18.0475 |
| 10:15 ET | 200 | 18.0103 |
| 10:17 ET | 1301 | 17.9 |
| 10:24 ET | 200 | 17.9 |
| 10:26 ET | 100 | 17.9 |
| 10:28 ET | 100 | 17.915 |
| 10:32 ET | 386 | 17.8901 |
| 10:33 ET | 100 | 17.915 |
| 10:37 ET | 225 | 17.8949 |
| 10:39 ET | 2336 | 17.935 |
| 10:42 ET | 100 | 17.92 |
| 10:44 ET | 350 | 17.87 |
| 10:48 ET | 390 | 17.76 |
| 10:50 ET | 2119 | 17.8 |
| 10:51 ET | 5367 | 17.8214 |
| 10:55 ET | 5100 | 17.83 |
| 10:57 ET | 700 | 17.825 |
| 11:00 ET | 672 | 17.835 |
| 11:02 ET | 400 | 17.835 |
| 11:04 ET | 100 | 17.83 |
| 11:08 ET | 300 | 17.87 |
| 11:09 ET | 974 | 17.92 |
| 11:15 ET | 2473 | 17.955 |
| 11:18 ET | 100 | 18.01 |
| 11:20 ET | 100 | 18.01 |
| 11:22 ET | 100 | 18 |
| 11:24 ET | 200 | 18.007 |
| 11:26 ET | 1402 | 17.955 |
| 11:29 ET | 203 | 17.84 |
| 11:31 ET | 100 | 17.875 |
| 11:33 ET | 400 | 17.875 |
| 11:36 ET | 356 | 17.855 |
| 11:38 ET | 200 | 17.866 |
| 11:40 ET | 500 | 17.866 |
| 11:42 ET | 300 | 17.866 |
| 11:44 ET | 200 | 17.866 |
| 11:45 ET | 968 | 17.85 |
| 11:47 ET | 1318 | 17.9 |
| 11:49 ET | 2191 | 17.89 |
| 11:54 ET | 4345 | 17.81 |
| 11:56 ET | 100 | 17.805 |
| 12:00 ET | 300 | 17.805 |
| 12:03 ET | 100 | 17.805 |
| 12:05 ET | 2300 | 17.71 |
| 12:07 ET | 100 | 17.68 |
| 12:09 ET | 173 | 17.67 |
| 12:12 ET | 804 | 17.665 |
| 12:14 ET | 1200 | 17.605 |
| 12:18 ET | 2200 | 17.605 |
| 12:21 ET | 171 | 17.61 |
| 12:23 ET | 1968 | 17.65 |
| 12:25 ET | 263 | 17.65 |
| 12:27 ET | 250 | 17.68 |
| 12:30 ET | 200 | 17.69 |
| 12:36 ET | 100 | 17.69 |
| 12:41 ET | 2545 | 17.785 |
| 12:48 ET | 100 | 17.785 |
| 12:52 ET | 567 | 17.74 |
| 12:54 ET | 100 | 17.755 |
| 12:56 ET | 142 | 17.77 |
| 12:57 ET | 457 | 17.76 |
| 12:59 ET | 100 | 17.76 |
| 01:01 ET | 292 | 17.76 |
| 01:03 ET | 388 | 17.77 |
| 01:06 ET | 157 | 17.77 |
| 01:08 ET | 571 | 17.75 |
| 01:10 ET | 875 | 17.78 |
| 01:12 ET | 100 | 17.77 |
| 01:14 ET | 500 | 17.79 |
| 01:24 ET | 548 | 17.75 |
| 01:26 ET | 600 | 17.76 |
| 01:28 ET | 591 | 17.77 |
| 01:30 ET | 365 | 17.79 |
| 01:32 ET | 902 | 17.795 |
| 01:39 ET | 180 | 17.82 |
| 01:42 ET | 100 | 17.81 |
| 01:44 ET | 187 | 17.805 |
| 01:51 ET | 340 | 17.794 |
| 01:53 ET | 1102 | 17.82 |
| 02:00 ET | 1037 | 17.81 |
| 02:02 ET | 157 | 17.81 |
| 02:04 ET | 100 | 17.82 |
| 02:06 ET | 100 | 17.805 |
| 02:08 ET | 147 | 17.805 |
| 02:09 ET | 305 | 17.81 |
| 02:13 ET | 200 | 17.81 |
| 02:15 ET | 100 | 17.83 |
| 02:18 ET | 100 | 17.81 |
| 02:20 ET | 701 | 17.845 |
| 02:24 ET | 200 | 17.9 |
| 02:26 ET | 1500 | 17.9 |
| 02:27 ET | 200 | 17.905 |
| 02:29 ET | 14030 | 17.925 |
| 02:31 ET | 6900 | 17.82 |
| 02:36 ET | 463 | 17.85 |
| 02:38 ET | 100 | 17.87 |
| 02:42 ET | 200 | 17.88 |
| 02:44 ET | 630 | 17.89 |
| 02:45 ET | 200 | 17.89 |
| 02:47 ET | 3153 | 17.8 |
| 02:49 ET | 742 | 17.79 |
| 02:51 ET | 623 | 17.75 |
| 02:54 ET | 590 | 17.7265 |
| 02:56 ET | 784 | 17.769 |
| 03:00 ET | 930 | 17.79 |
| 03:02 ET | 150 | 17.785 |
| 03:07 ET | 1318 | 17.79 |
| 03:12 ET | 200 | 17.829 |
| 03:14 ET | 1474 | 17.86 |
| 03:16 ET | 385 | 17.85 |
| 03:18 ET | 200 | 17.85 |
| 03:20 ET | 948 | 17.82 |
| 03:23 ET | 405 | 17.83 |
| 03:25 ET | 3106 | 17.855 |
| 03:27 ET | 1188 | 17.8666 |
| 03:30 ET | 6961 | 17.82 |
| 03:32 ET | 483 | 17.8 |
| 03:34 ET | 2207 | 17.78 |
| 03:38 ET | 1672 | 17.815 |
| 03:39 ET | 304 | 17.79 |
| 03:41 ET | 889 | 17.83 |
| 03:43 ET | 1300 | 17.82 |
| 03:48 ET | 4229 | 17.81 |
| 03:50 ET | 2620 | 17.86 |
| 03:52 ET | 8075 | 17.82 |
| 03:54 ET | 5772 | 17.86 |
| 03:56 ET | 6491 | 17.895 |
| 03:57 ET | 8756 | 17.94 |
| 03:59 ET | 444479 | 17.95 |
May 15, 2024
DJ Harrow Is Maintained at Buy by Craig-Hallum, from 2:02PM ET on Wednesday May 15, 2024 by Dow Jones
2:02PM ET on Wednesday May 15, 2024 by Dow JonesDJ Harrow Price Target Raised to $29.00/Share From $26.00 by B. Riley Securities, from 10:22AM ET on Wednesday May 15, 2024 by Dow Jones
10:22AM ET on Wednesday May 15, 2024 by Dow JonesHarrow to Present at Two Investor Conferences in May, from 7:00AM ET on Wednesday May 15, 2024 by Dow Jones
7:00AM ET on Wednesday May 15, 2024 by Dow Jones
May 14, 2024
DJ Harrow Up Over 35%, On Track for Largest Percent Increase Since November 2012 -- Data Talk, from 12:50PM ET on Tuesday May 14, 2024 by Dow Jones
12:50PM ET on Tuesday May 14, 2024 by Dow Jones
May 13, 2024
DJ Harrow Shares Gain After Backing FY Guidance, from 6:51PM ET on Monday May 13, 2024 by Dow Jones
6:51PM ET on Monday May 13, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Harrow Inc | 635.1M | -19.8x | --- |
SIGA Technologies Inc | 532.0M | 6.8x | -28.78% |
Esperion Therapeutics Inc | 409.2M | -2.1x | --- |
Bavarian Nordic A/S | 2.1B | 14.3x | --- |
Xeris Biopharma Holdings Inc | 334.3M | -4.9x | --- |
EyePoint Pharmaceuticals Inc | 557.8M | -5.9x | --- |
Company Information
Harrow, Inc. is an eyecare pharmaceutical company. The Company is engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the United States market. It provides a comprehensive portfolio of prescription and non-prescription pharmaceutical products. It owns commercial rights to portfolios of branded ophthalmic pharmaceutical products in North America, all of which are marketed under the Harrow name. It owns and operates ImprimisRx, an ophthalmology-focused pharmaceutical-compounding business. It owns United States commercial rights to various products: IHEEZO, VEVYE, TRIESENCE, VIGAMOX, ILEVRO, FLAREX, NATACYN, ZERVIATE and others. VIGAMOX (moxifloxacin hydrochloride ophthalmic solution) 0.5%, a fluoroquinolone antibiotic eye drops for the treatment of bacterial conjunctivitis caused by susceptible strains of organisms. IHEEZO (chloroprocaine hydrochloride ophthalmic gel) 3% is a low-viscosity gel indicated for ocular surface anesthesia.
Contact Information
- Headquarters
- 102 WOODMONT BLVD, SUITE 610NASHVILLE, TN, United States 37215
- Phone
- 615-733-4731
- Fax
- 858-345-1745
Executives
- Chairman of the Board, Chief Executive Officer
- Mark Baum
- Chief Financial Officer, Corporate Secretary
- Andrew Boll
- President and Chief Executive Officer of ImprimisRx, Chief Commercial Officer
- John Saharek
- Director
- Adrienne Graves
- Director
- Lauren Silvernail
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $635.1M |
|---|---|
Revenue (TTM) | $138.7M |
Shares Outstanding | 35.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.88 |
EPS | $-0.91 |
Book Value | $2.01 |
P/E Ratio | -19.8x |
Price/Sales (TTM) | 4.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -5.56% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
